Too Old to Treat? Rethinking Steroid-sparing Therapy in Elderly-onset Inflammatory Bowel Disease
- 12 May 2025
- journal article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 24 (2) , 572-573
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Risk of Age-related and Disease-related Complications and Mortality in Elderly-onset Inflammatory Bowel Disease: A Population-based StudyClinical Gastroenterology and Hepatology, 2025
- Treatment of inflammatory bowel disease with steroid‐sparing medications is age‐dependent – Results from a Danish nationwide cohort study, 2000–2018Alimentary Pharmacology & Therapeutics, 2024
- Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRNJournal of Crohn's and Colitis, 2021
- Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in SwedenGastroenterology, 2018
- Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age—An Increasing Distinct Entity?Inflammatory Bowel Diseases, 2016
- Natural history of elderly-onset inflammatory bowel disease: a population-based cohort studyGut, 2013
- Epidemiology of inflammatory bowel diseases: New insights from a French population-based registry (EPIMAD)Digestive and Liver Disease, 2013